Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy

被引:0
|
作者
M. Kalder
I. Kyvernitakis
U. S. Albert
M. Baier-Ebert
P. Hadji
机构
[1] Philipps University of Marburg,Department of Obstetrics and Gynecology
[2] Krankenhaus Nordwest,Department of Obstetrics and Gynecology
[3] Novartis Pharma GmbH,Clinical & Regulatory Affairs/Biometrics Department
[4] Krankenhaus Nordwest,Department of Bone Oncology, Endocrinology and Reproductive Medicine
来源
关键词
Bone mineral density; Breast cancer; Osteoporosis; Trabecular bone score; Zoledronic acid;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:353 / 360
页数:7
相关论文
共 50 条
  • [41] Effect of zoledronic acid on bone mineral density in thalassemia-induced osteoporosis: Results of a phase II clinical trial.
    Taher, A
    Azar, S
    Shamseddeen, W
    Habr, D
    Inati, A
    Koussa, S
    Mahfouz, R
    Otrock, Z
    BLOOD, 2005, 106 (11) : 36B - 36B
  • [42] The Effect of Bone-Loading Exercise on Bone Mineral Density in Women Following Treatment for Breast Cancer: A Systematic Review and Meta-analysis
    Zerzan, Sarah
    Smoot, Betty
    Lee, Jeannette Q.
    Lui, Andrew
    Allen, Diane D.
    REHABILITATION ONCOLOGY, 2016, 34 (04) : 144 - 155
  • [43] Effects of additional resistance training during diet-induced weight loss on bone mineral density in overweight premenopausal women
    Nakata, Yoshio
    Ohkawara, Kazunori
    Lee, Dong Jun
    Okura, Tomohiro
    Tanaka, Kiyoji
    JOURNAL OF BONE AND MINERAL METABOLISM, 2008, 26 (02) : 172 - 177
  • [44] Effects of additional resistance training during diet-induced weight loss on bone mineral density in overweight premenopausal women
    Yoshio Nakata
    Kazunori Ohkawara
    Dong Jun Lee
    Tomohiro Okura
    Kiyoji Tanaka
    Journal of Bone and Mineral Metabolism, 2008, 26 : 172 - 177
  • [45] Adverse effects of adjuvant tamoxifen treatment on bone mineral density in premenopausal breast cancer patients: A systematic review and meta-analysis.
    Cha, Chihwan
    Lee, Soo Jin
    Hong, Hanpyo
    Choi, Yun Young
    Chung, Min Sung
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Steger, G. G.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 3
  • [47] Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer:: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
    Gnant, Michael
    Mlineritsch, Brigitte
    Luschin-Ebengreuth, Gero
    Kainberger, Franz
    Kaessmann, Helmut
    Piswanger-Soelkner, Jutta Claudia
    Seifert, Michael
    Ploner, Ferdinand
    Menzel, Christian
    Dubsky, Peter
    Fitzal, Florian
    Bjelic-Radisic, Vesna
    Steger, Guenther
    Greil, Richard
    Marth, Christian
    Kubista, Ernst
    Samonigg, Hellmut
    Wohlmuth, Peter
    Mittlboeck, Martina
    Jakesz, Raimund
    LANCET ONCOLOGY, 2008, 9 (09): : 840 - 849
  • [48] Effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women
    Barni, S
    Lissoni, P
    Tancini, G
    Ardizzoia, A
    Cazzaniga, M
    TUMORI, 1996, 82 (01) : 65 - 67
  • [49] Bone mineral density, Gail score and breast cancer risk - Results from a subcohort in the women's health initiative (WHI).
    Arendell, L. A.
    Chlebowski, R.
    Aickin, M.
    Cauley, J. A.
    Lewis, C. E.
    Chen, Z.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S267 - S267
  • [50] Zoledronic acid (ZA) for prevention of cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (let): Preliminary results of the Z-FAST trial
    Brufsky, A
    Harker, G
    Beck, T
    Carroll, R
    Tan-Chiu, E
    Seidler, C
    Lacema, L
    Thomas, E
    Perez, E
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S233 - S233